China FDA Imposes Big Drug And Device Fee Hikes
This article was originally published in PharmAsia News
Executive Summary
Drug manufacturers looking to get their products approved in China are facing a massive spike in registration fees for their products, as the China FDA makes a bid to cover its increasing costs to process applications.